Y10S 435/908
Streptovirticillium
Y10S435/908 (Streptovirticillium) appears on 16 US grants and 0 published applications in this corpus.
Search patents in Y10S- Granted patents
- 16
- Published applications
- 0
- Assignees
- 10
- Inventors
- 44
- Latest grant
- 22 May 2001
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Biocatalysts with amine acylase activity22 May 2001US 6,235,516 B1Novartis AG
- Streptoverticillium ferm P-10489 which produces antitumor agent BE-13793C1 Mar 1994US 5,290,698 ABanyu Pharmaceutical Co., Ltd.
- Antitumor substance BE-13793C8 Jun 1993US 5,217,885 ABanyu Pharmaceutical Co., Ltd.
- Antitumor substance BE-13793C21 Apr 1992US 5,106,864 ABanyu Pharmaceutical Co., Ltd.
- Process for producing L-654,040, antibacterial agent2 Oct 1990US 4,960,698 AMerck & Co., Inc.
No published applications in this class yet.
Most cited
By later US patents
- Protein product of reduced nucleic acid content and low allergenicity12US 4,601,986 APhillips Petroleum Company · 1986
- Antitumor substance BE-13793C10US 5,106,864 ABanyu Pharmaceutical Co., Ltd. · 1992
- Process for microbial production of an optically active 3-(3,4-dihydroxyphenyl)serine9US 4,699,879 ABanyu Pharmaceutical Co., Ltd. · 1987
- Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation5US 4,141,972 ASanraku-Ocean Co., Ltd. · 1979
- Pentadecapeptide4US 4,452,782 AHoffmann-La Roche Inc. · 1984